Tech entrepreneur and antiaging company founder Bryan Johnson is reevaluating his role at Blueprint, the antiaging company he launched to promote wellness and extend human life. Johnson, 47, known for his bold longevity experiments and high-profile lifestyle, recently hinted he might exit the antiaging company space to dedicate himself fully to his new religion, “Don’t Die.”
Speaking to Wired, Johnson expressed frustration with managing his antiaging company, stating, “I don’t need the money, and it’s a pain-in-the-ass company.” This candid admission suggests a growing disconnect between his personal philosophical pursuits and his business responsibilities. He added that he’s considered shutting down or selling the antiaging company, although discussions are ongoing.
Johnson’s journey into the longevity world began with Project Blueprint, a rigorous anti-aging protocol costing $2 million annually. His antiaging company Blueprint commercialized many aspects of that lifestyle, offering products like a $55 longevity drink and a $42 mushroom coffee replacement. But now, Johnson feels this enterprise may undermine the philosophical integrity of his new mission.
In March, Johnson introduced “Don’t Die,” a religion he claims is inspired by a future vision of humanity merging with AI to transcend death. Despite the synergy in purpose, he believes the existence of a profit-driven antiaging company raises questions about his authenticity as a philosophical leader. “The problem is now people see the business and give me less credibility on the philosophy side,” he explained.
However, Johnson later backtracked slightly. After Business Insider covered his remarks, he clarified via X (formerly Twitter) that the Wired interview had occurred months earlier. He then affirmed his commitment to Blueprint, saying, “The truth is that I need Blueprint. The world needs Blueprint.” Johnson now plans to merge the antiaging company with his religion, hiring a CEO and CTO to lead operations so he can focus on “Don’t Die.”
While internal and external reports previously hinted at financial troubles at the antiaging company, Johnson refuted these claims. He acknowledged that Blueprint had fluctuating monthly results but maintained it had achieved break-even in some periods. “We are break-even, and I’ve said that publicly many times,” he insisted.
In an earlier post, Johnson said he was hiring a company president with a $250,000 salary to oversee daily operations while he devoted mental energy entirely to his religious philosophy. As of now, executive roles such as CEO and CTO have not appeared on the company’s careers page, suggesting ongoing internal changes at the antiaging company.
Ultimately, Bryan Johnson’s decision to step back from direct control of his antiaging company reflects his evolving identity. Once the face of extreme longevity innovation, he now sees a greater purpose in spiritual transformation, even as Blueprint continues to serve as the platform for his biohacking legacy.
